Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-06 18:00 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 167.0 KB | ||
| 2020-08-06 17:45 |
AMOEBA annonce l’émission de la cinquième tranche de 26 obligations convertible…
|
French | PDF • 269.9 KB | ||
| 2020-08-06 17:45 |
AMOEBA announces the issuance of the fifth tranche of 26 bonds convertible into…
|
English | PDF • 209.7 KB | ||
| 2020-07-27 08:00 |
AMOEBA : l’efficacité de la solution de biocontrôle contre le mildiou de la vig…
|
French | PDF • 266.3 KB | ||
| 2020-07-27 08:00 |
AMOEBA: the efficacy of the biocontrol solution against grapevine downy mildew …
|
English | PDF • 176.7 KB | ||
| 2020-07-22 17:45 |
AMOEBA : les essais au champ confirment l’efficacité de la solution de biocontr…
|
French | PDF • 255.6 KB | ||
| 2020-07-22 17:45 |
AMOEBA: field tests confirm the efficacy of Amoeba's biocontrol solution on sev…
|
English | PDF • 182.5 KB | ||
| 2020-07-06 17:45 |
AMOEBA annonce l’émission de la quatrième tranche de 26 obligations convertible…
|
French | PDF • 261.5 KB | ||
| 2020-07-06 17:45 |
AMOEBA announces the issuance of the fourth tranche of 26 bonds convertible int…
|
English | PDF • 214.3 KB | ||
| 2020-07-06 08:00 |
AMOEBA : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
|
French | PDF • 313.7 KB | ||
| 2020-07-01 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 145.9 KB | ||
| 2020-06-24 18:15 |
AMOEBA : DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS AUTORISE PAR L’ASSEMBLEE G…
|
French | PDF • 237.3 KB | ||
| 2020-06-24 17:45 |
AMOEBA : APPROBATION PAR L'ASSEMBLEE GENERALE DU 24 JUIN 2020 DU TRANSFERT DES …
|
French | PDF • 291.6 KB | ||
| 2020-06-24 17:45 |
AMOEBA: APPROVAL BY THE ANNUAL GENERAL MEETING OF JUNE 24, 2020 OF THE TRANSFER…
|
English | PDF • 160.9 KB | ||
| 2020-02-24 17:45 |
AMOEBA : Assemblée Générale Ordinaire et Extraordinaire du 13 mars 2020 /modali…
|
French | PDF • 164.1 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
